IREN's 5GW Pipeline Expands, but Execution Risk Keeps Rating at WAIT

What happened

IREN has secured over 5GW of power capacity and $16.6 billion in contracted backlog, yet only $1.0 billion of AI annual recurring revenue is currently operating. The latest commentary from Zacks highlights the company's rapid pivot to AI infrastructure but questions whether execution can match ambition. Despite the pipeline, customer acceptance milestones and financing tied to those milestones remain the primary gating factors for revenue recognition. The stock at $44.68 already prices in a smooth conversion of backlog to revenue, leaving little margin for error. Investors now focus on near-term proof points such as Microsoft Horizons 2-4 acceptance and first meaningful lease revenue, rather than further contract announcements.

Implication

The new article reinforces the existing thesis that IREN's value hinges on converting contracted capacity into accepted, billable service. Investors should monitor acceptance timelines and financing draws closely, as any slippage could lead to significant downside given the stock's reliance on future revenue. Positive catalysts include timely Microsoft and Mackenzie acceptances and rising operating ARR above $1.5 billion. Conversely, new equity issuance or further delays would undermine the bull case and justify a lower valuation. Until there is concrete evidence of revenue conversion, a neutral stance with an attractive entry below $34 is prudent.

Thesis delta

The new article does not add materially new information beyond what was reflected in the prior report; it echoes the market's shift from narrative to proof. The core thesis—that IREN has valuable power assets but faces execution and dilution risks—remains unchanged. No adjustment to the WAIT rating or valuation scenarios is warranted at this time.